Advances in clinical pharmacology最新文献_第2页

[Aminoglycosides in urology]. [泌尿外科的氨基糖苷]。

Advances in clinical pharmacology Pub Date : 1978-01-01

A Hofstetter

引用次数: 0

[The differentiation of potential nephrotoxicity of various aminoglycosides in animal experiments]. [动物实验中不同氨基糖苷潜在肾毒性的分化]。

Advances in clinical pharmacology Pub Date : 1978-01-01

K Sack, H Freiesleben, B Züllich, H Beck, E Schulz

{"title":"[The differentiation of potential nephrotoxicity of various aminoglycosides in animal experiments].","authors":"K Sack, H Freiesleben, B Züllich, H Beck, E Schulz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Experimental differentiation in the animal of nephrotoxicity of various aminoglycosides. Animal experiments showed that all aminoglycosides cause similar toxic tubular and glomerular damage when investigated by qualitative morphology. Quantitative differences in tubular nephrotoxicity of gentamicin, tobramycin, sisomicin, kanamycin, kanendomycin, amikacin, and butirosin were demonstrable by evaluation of the excretion rates of tubular cells and urinary enzymes in rats. By this means dose-effect-relationships were found resulting in reproducible different toxic threshold doses for each antibiotic, and thus in a scale of increasing nephrotoxicity. The aminoglycosides differed by their affinity to kidney tissue as measured by determination of the accumulating renal concentrations of the drugs at different times during multiple-dose administration. This had a modifying influence on excretion rates of cells and enzymes affecting the scale of toxicity in long-term studies. Comparative investigations on nephrotoxicity in rats and guinea pigs gave similar results. In addition, a study in man suggested that the test results of nephrotoxicity are not species-specific. For human therapy it is concluded that even more caution should be practised with the new aminoglycosides than with gentamicin in order to avoid renal damage.</p>","PeriodicalId":75437,"journal":{"name":"Advances in clinical pharmacology","volume":"15 ","pages":"69-90"},"PeriodicalIF":0.0,"publicationDate":"1978-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11877978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Experience with mexiletine in the occurrence of ventricular arrhythmias in the acute phase of myocardial infarct]. 【美西汀治疗心肌梗死急性期室性心律失常的经验】。

Advances in clinical pharmacology Pub Date : 1978-01-01

H Koller, H Prager, H Sterz

引用次数: 0

[New data on the ototoxicity of aminoglycoside antibiotics]. [氨基糖苷类抗生素耳毒性的新数据]。

Advances in clinical pharmacology Pub Date : 1978-01-01

P Federspil

引用次数: 0

[Short-and long-term therapy with Mexitil]. [美西替尔的短期和长期治疗]。

Advances in clinical pharmacology Pub Date : 1978-01-01

H Esser, D Kikis